United States · Bill · HR
H.R. 2181 (117th)
Affordable and Safe Prescription Drug Importation Act
Introduced
23 March 2021
Last action
24 March 2021 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Sen. Welch, Peter [D-VT], Rep. Bush, Cori [D-MO-1], Rep. Doggett, Lloyd [D-TX-37], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Pocan, Mark [D-WI-2], Rep. Khanna, Ro [D-CA-17], Rep. Neguse, Joe [D-CO-2], Rep. Omar, Ilhan [D-MN-5], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Blumenauer, Earl [D-OR-3], Rep. Garamendi, John [D-CA-8], Rep. Pingree, Chellie [D-ME-1], Rep. Raskin, Jamie [D-MD-8], Rep. Grijalva, Raúl M. [D-AZ-7], Rep. Mrvan, Frank J. [D-IN-1], Rep. Jones, Mondaire [D-NY-17], Rep. Cohen, Steve [D-TN-9]
Subjects
Healthcare
Source updated
5 December 2025
Summary
Affordable and Safe Prescription Drug Importation Act This bill allows expanded importation of eligible prescription drugs and addresses related issues. Current law allows the Department of Health and Human Services (HHS) to authorize the importation of certain eligible prescription drugs from Canada if HHS certifies to Congress that doing so would pose no additional risk to public health and safety and would result in significant cost savings for consumers. The bill removes this certification requirement and requires HHS to issue regulations that permit the importation of qualifying prescription drugs from Canada. After a certain amount of time, HHS may authorize importation from certain other countries if it determines that importation from Canada has resulted in cost savings for consumers and increased access to safe medication. The bill also expands the types of prescription drugs eligible for importation to include, for example, biologics such as insulin. Furthermore, the bill allows individuals to use an eligible licensed foreign pharmacy to fill a U.S.-issued prescription for a qualifying drug for personal use. Currently, an individual seeking to import a prescription drug generally must acquire a waiver from HHS. The bill imposes various requirements related to certification of foreign sellers, labeling of imported drugs, and supply chain security. The bill also (1) prohibits certain acts that discriminate against foreign sellers, such as charging higher prices to foreign sellers than to other sellers in the same country; and (2) imposes criminal penalties for online websites that sell counterfeit drugs or dispense drugs without a required prescription.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
23 March 2021
Introduced
Introduced in House
Source: IntroReferral
23 March 2021
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
23 March 2021
Introduced
Introduced in House
Source: IntroReferral
24 March 2021
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 23 March 2021 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 23 March 2021
Introduced in House (PDF)
Introduced in House · EN · 23 March 2021
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 23 March 2021
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Sen. Welch, Peter [D-VT] · D · Sponsor
- Rep. Bush, Cori [D-MO-1] · D · Sponsor
- Rep. Doggett, Lloyd [D-TX-37] · D · Sponsor
- Del. Norton, Eleanor Holmes [D-DC-At Large] · D · Sponsor
- Rep. Pocan, Mark [D-WI-2] · D · Sponsor
- Rep. Khanna, Ro [D-CA-17] · D · Sponsor
- Rep. Neguse, Joe [D-CO-2] · D · Sponsor
- Rep. Omar, Ilhan [D-MN-5] · D · Sponsor
- Rep. Schakowsky, Janice D. [D-IL-9] · D · Sponsor
- Rep. Blumenauer, Earl [D-OR-3] · D · Cosponsor
- Rep. Garamendi, John [D-CA-8] · D · Cosponsor
- Rep. Pingree, Chellie [D-ME-1] · D · Cosponsor
- Rep. Raskin, Jamie [D-MD-8] · D · Cosponsor
- Rep. Grijalva, Raúl M. [D-AZ-7] · D · Cosponsor
- Rep. Mrvan, Frank J. [D-IN-1] · D · Cosponsor
- Rep. Jones, Mondaire [D-NY-17] · D · Cosponsor
- Rep. Cohen, Steve [D-TN-9] · D · Cosponsor
- · hsif00 · Standing
Related records
- related to → Affordable and Safe Prescription Drug Importation Act
- related to ← Affordable Medications Act
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-bill/2181
- Open data entity: https://api.congress.gov/v3/bill/117/hr/2181
- us · 117-hr-2181 · source updated 5 December 2025